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Abstract Several studies have reported associations
between brain iron deposits and cognitive status, and
cardiovascular and neurodegenerative diseases in older
individuals, but the mechanisms underlying these asso-
ciations remain unclear. We explored the associations
between regional brain iron deposits and different fac-
tors of cognitive ability (fluid intelligence, speed and
memory) in a large sample (n=662) of individuals with
a mean age of 73 years. Brain iron deposits in the corpus
striatum were extracted automatically. Iron deposits in
other parts of the brain (i.e., white matter, thalamus,
brainstem and cortex), brain tissue volume and white
matter hyperintensities (WMH) were assessed separate-
ly and semi-automatically. Overall, 72.8 % of the
sample had iron deposits. The total volume of iron
deposits had a small but significant negative association
with all three cognitive ability factors in later life (mean
r=−0.165), but no relation to intelligence in childhood
(r=0.043, p=0.282). Regression models showed that
these iron deposit associations were still present after
control for a variety of vascular health factors, and were
separable from the association of WMH with cognitive
ability. Iron deposits were also associated with cognition
across the lifespan, indicating that they are relevant for
cognitive ability only at older ages. Iron deposits might
be an indicator of small vessel disease that affects the
neuronal networks underlying higher cognitive
functioning.
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Introduction
As people grow older, iron accumulates, mainly in the
form of hemosiderin, in several brain regions and cell
types (Valdés Hernández et al. 2012; Ward et al. 2014).
The causes of these iron deposits, and their conse-
quences for human cognitive ageing, remain unclear.
Initial evidence indicates that they are related to lower
cognitive ability in later life (Penke et al. 2012) and to a
variety of neurological diseases (e.g., Brass et al. 2006).
In the present study, we analyse data from a large sample
of individuals aged around 73 years, building a picture
of where in the brain most iron deposits are found, and
testing their relations with multiple cognitive abilities
and vascular risk factors.
Several sources of iron deposition have been described
in older and cognitively normal brains. Macroscopic
mineralised ‘pools’, predominant in ferritin and hemosider-
in, mainly localised in and around the small lenticulostriate
arterioles of the corpus striatum (Casanova and Araque
2003; Aquino et al. 2009), are the main contributors to the
abnormal iron accumulation detectable using magnetic res-
onance images (MRI). This deposition gradually occurs and
has been mainly attributed to dysfunctional brain iron reg-
ulatorymechanisms including abnormal permeability of the
vessel walls and glial cell dysfunction (McCarthy and
Kosman 2014). Small chronic haemorrhages, in different
forms and locations, are also sources of macroscopic iron
deposition: brain microbleeds and superficial siderosis are
two of the types most commonly found in older brains.
Brain microbleeds, tiny deposits of blood degradation prod-
ucts contained within macrophages, are in close spatial
relationship with structurally abnormal vessels (Martinez-
Ramirez et al. 2014). Superficial siderosis manifests in the
subpial layers of the brain as hemosiderin accumulation,
due to recurrent and persistent bleeding into the subarach-
noid space (Kumar 2009).
Previous studies have found associations between
higher levels of brain iron deposits in deep grey matter
structures and lower cognitive ability (Sullivan et al. 2009;
van Es et al. 2008; Daugherty et al. 2015; Rodriguez et al.
2013), as well as neurodegenerative diseases (Thompson
et al. 2001; Wallis et al. 2008; McNeill et al. 2008; Kruer
et al. 2012; Brass et al. 2006). Microbleeds have been
associated with cerebrovascular diseases (Fazekas et al.
1999; Cordonnier et al. 2007). A previous study of a subset
of the cohort analysed in this paper (the Lothian Birth
Cohort 1936 (LBC1936); Penke et al. 2012) showed an
association between the volume of iron deposits (primarily
in the basal ganglia) and poorer general cognitive ability.
However, with data from only 143 individuals, it had
relatively low statistical power, increasing the chances of
erroneous results. In addition, it did not analyse other
variables, such as vascular risk factors, and white matter
hyperintensities (WMH) that could be potentially related to
brain iron deposition. In this paper, we report data on the
iron deposition levels and locations for the full cohort (n=
676with relevantMRI data), alongwith the relations of the
volume of iron deposits to cognitive and vascular health.
In addition, the Lothian Birth Cohort 1936 has avail-
able a measure of childhood intelligence, taken at age 11.
In the subsample analysed by Penke et al. (2012), cogni-
tive ability from early life predicted the volume of iron
deposition in the brain at age 73. The latter was related to
lifetime cognitive ability (that is, iron deposit volume
related to later-life cognitive ability after controlling for
early life cognitive ability). Whether these associations
hold for a bigger sample needs to be investigated.
Here, we also investigate a second hypothesis, related
to WMH: hyperintensities observed in the white matter
and subcortical grey matter on fluid attenuation inver-
sion recovery (FLAIR) and T2W structural MRI; which
are common in older brains and may have similar asso-
ciations with indicators of cognitive ability as brain iron
deposits (Valdés Hernández et al. 2013a; Wardlaw et al.
2013). Iron deposits in the globus pallidus have been
associated with the total brain WMH volume (Yan et al.
2013). A detailed characterisation of corpus striatum
(i.e., basal ganglia and internal capsule) multifocal
T2*W hypointensities on MRI from an ageing sample
concluded that their spatial distribution and multifocal
morphology suggest they could be associated with prox-
imal mineralised lenticulostriate arteriolar walls and
perivascular structures (Glatz et al. 2013). Iron deposits
may, therefore, have a mainly vascular origin, like the
WMH found in deep grey and white matter (Kim et al.
2008). However, it is unclear whether the presence of
iron deposits has effects on cognitive ability beyond
those of WMH. In this study, we test whether iron
deposits are still related to cognitive ability even after
taking into account the association with WMH.
After describing the regional locations of the brain
iron deposits in our sample, we focus on three questions.
First, do iron deposits predict cognitive ability, and do
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they do so even after control for a range of health factors?
We test this hypothesis using a series of linear regression
models. Second, do iron deposits still relate to cognitive
ability after taking into account the association with
WMH? If separate effects are found, this would be evi-
dence consistent with additive detrimental effects of iron
deposits and WMH on cognitive abilities. If the associa-
tion with iron deposits is no longer present after adjusting
for WMH, it would imply that iron deposits are epiphe-
nomena of other processes and are not themselves pre-
dictive of cognitive ability. Third, we estimate models
that test whether iron deposits relate to lifetime cognitive
ability, using the age-11 intelligence data in our sample as
a control variable. If iron deposits relate to cognition
across the life course, we would expect still to find an
association between iron deposit volume and cognitive
ability at old age when we account for childhood intelli-
gence like we found before on a smaller sample.
Materials and methods
Subjects
From the Lothian Birth Cohort 1936 (LBC1936), which
comprises community-dwelling surviving members of the
Scottish Mental Survey of 1947 (Deary et al. 2007), 700
participants (328 females and 372 males) had an MRI
brain scan at mean age 72.7 years old (SD 0.7, range
71.1 to 74.3). From the 700 brain image sets, 676 had
the relevant sequences to assess brain iron deposition and
WMH. Three scans were additionally excluded due to the
presence of extensive hemosiderin deposition caused by
previous haemorrhages. However, the final sample size
slightly varied across analyses depending on the cognitive
and imaging data available. Each participant’s history of
diabetes, hypertension, hypercholesterolaemia, cardiovas-
cular disease and stroke was taken from their self-reported
medical history. Written informed consent was obtained
from all participants under protocols approved by the
Lothian (REC 07/MRE00/58) and Scottish Multicentre
(MREC/01/0/56) Research Ethics Committees.
MRI scans
MRI scans were acquired using a 1.5 T GE Signa
Horizon HDxt clinical scanner (General Electric,
Milwaukee, WI, USA) operating in research mode and
using a self-shielding gradient set with maximum
gradient of 33 mT/m and an 8-channel phased-array
head coil. The imaging protocol is fully described in
(Wardlaw et al. 2011). For this particular study, we used
the coronal T1W volumes acquired with a 3D inversion
recovery prepared fast gradient echo sequence (TR/TE/
TI=9.7:3.984:500 ms, flip angle α=8 °, bandwidth
15.63 kHz, voxel size 1×1×1.3 mm3), the axial
FLAIR volumes (TR/TE/TI=9000:140:2200 ms,
bandwith 15.63 kHz, voxel size 1×1×4 mm3) and the
axial T2*W volumes acquired with a 2D gradient echo
sequence (GRASS, TE/TR=15:940 ms, flip angle α=
20 °, bandwidth 12.5 kHz, voxel size 1×1×2 mm3).
None of these sequences had interslice gap and, for all,
the FOV in the acquisition plane was 256×256 mm2.
Brain iron deposits
For extracting and quantifying the brain volume occupied
by iron deposits, we used the pre-processing pipeline
described in Glatz et al. (2012, 2015) and applied compu-
tational methods that use T1Wand T2*WMRI sequences
to ensure that we only include non-calcified regions rich in
methemoglobin, hemosiderin and/or ferritin (Valdés
Hernández et al. 2012, 2014; Vymazal et al. 1999).
Diffuse and morphometrically heterogeneous iron
deposits in the corpus striatum
Multifocal T2*W hypointensities in the structures of the
corpus striatum that can appear uniformly spatially dis-
tributed on amorphometrically irregular cluster or group
of clusters on structural MRI, were assessed fully auto-
matically using the method described in Glatz et al.
(2015), freely available at https://github.com/aglatz/
mineral-deposit-segmentation-pipeline/tree/master/
libBRIC/mineral-deposit-segmentation, and reported
Jaccard similarity index=0.62±0.40 (Glatz et al.
2015). Briefly, T2*W hypointensities are segmented
with thresholds derived with an adaptive outlier
detection method from the bivariate T2*W/T1W
intensity distributions in each structure of the pre-
processed T1W/T2*W images. Artefacts are reduced
by filtering connected components in the binary masks
of the T2* hypointense clusters based on their
standardised T2*W intensity variance and appearance
on T1WMRI. The results of the automatic segmentation
were individually checked by an experienced analyst
blinded to any other imaging, cognitive and
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neurological information and manually rectified in the
few cases it was required.
Iron deposits in the brainstem, white matter, thalamus
and cortex
T2*W hypointensities in the brainstem, white matter,
thalamus and cortex were separately identified, extracted
and quantified on the pre-processed T2*W scans semi-
automatically using the ‘Object Counter’ module in
AnalyzeTM 10.0 following the process described in
Valdés Hernández et al. (2011, 2013a). A slice was
selected where the T2*W hypointensities appear, ideally
with a variety of shapes and intensities to adjust the
intensity threshold, starting from zero to less than half
of the median intensity value of the normal-appearing
white matter. An estimated maximum and minimum size
of the hypointense ‘objects’ was then adjusted interac-
tively. Binary masks of regional iron deposits were ob-
tained out from the intersection between the binarymasks
obtained from this semi-automatic process and the re-
gional regions-of-interest masks obtained from the pre-
processing pipeline. Manual editing followed the proto-
col described and validated in (Penke et al. 2012; Valdés
Hernández et al. 2011; Glatz et al. 2013).
Brain microbleeds and macrohaemorrhages
Brain microbleeds were visually assessed by an experi-
enced neuroradiologist using the Brain Observer Micro
Bleed Scale (BOMBS) (Cordonnier et al. 2007).
Macrohaemorrhages were also noted using a structured
template (Wardlaw et al. 2011). The sphericity and size
of the iron deposits computationally assessed was used
to evaluate the contribution of the ‘possible’ brain
microbleeds on the overall ID load, and, therefore on
the associations evaluated. The one-to-one correspon-
dence between visually detected ‘certain’ microbleeds
and the small spherical T2*W hypointensities computa-
tionally extracted was reported and examined. The pres-
ence of iron deposits in these regions with other possible
aetiology (e.g., superficial siderosis, previous haemor-
rhage) was annotated.
Intracranial, brain tissue and WMH volume
measurements
Volumes of the intracranial space (ICV), brain tissue and
WMH segmented as described inWardlaw et al. (2011),
were used in the analyses. Briefly, the ICV (i.e., contents
within the inner skull table including brain tissue, cere-
brospinal fluid, veins and dura), with an inferior limit on
the axial slice just superior to the tip of the odontoid peg
at the foramen magnum, was extracted semi-
automatically using the T2*W sequence, with the
Object Extraction Tool in AnalyzeTM 10.0 followed
by manually editing. WMH were segmented semi-
automatically on the quantised colour image obtained
after fusing co-registered FLAIR and T2*W se-
quences, mapping them in green and red respectively,
and applying minimum variance quantisation. This
technique is described and validated elsewhere
(Valdés Hernández et al. 2010) and implemented by
MCMxxxVI_ALE: tool freely available from (www.
sourceforge.net/projects/bric1936). On a randomly
selected subsample of 20 individuals from this
cohort, it had a substantial agreement (Jaccard
similarity index=0.61, 95 % confidence interval
(CI)=0.42) with WMH reference segmentations. ICV
was used to correct WMH volumes for head size. All
these measurements were also performed by a trained
image analyst blinded to participants’ clinical and
demographic information.
Cognitive testing and cognitive variables
We used cognitive measures obtained at the same time
as the MRI scan (mean age 72.7, SD 0.7 years). These
cognitive variables were fluid intelligence (g-fluid),
general processing speed (g-speed) and general memory
(g-memory). These latent general cognitive ability mea-
sures were generated using principal component analy-
sis from batteries of well-validated cognitive tests. For
g-fluid, we used six subtests of the WAIS-IIIUK
(Wechsler 1998): Digit Symbol Substitution, Digit
Span Backward, Symbol Search, Letter-Number
Sequencing, Block Design & Matrix Reasoning. g-
memory was derived from five subtests from the
WMS-IIIUK (Wechsler 1998)—Logical Memory Total
Immediate & Delayed Recall, Verbal Paired Associates
Immediate & Delayed Recall, and Spatial Span Total
Score—along with two subtests from the WAIS-IIIUK:
Letter-Number Sequencing and Digit Span Backward.
g-speed was obtained from two reaction time tests—
Simple Reaction Time and Choice Reaction Time—an
Inspection Time test, and two WAIS-IIIUK subtests:
Digit Symbol Substitution and Symbol Search.
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Statistical analyses
For all reported analyses, the total and regional iron and
WMH volumes were standardised by ICVand expressed
in percentage with respect to it. Age in days at the time of
the MRI scan and/or cognitive test was entered as a
covariate in all models to control for individual differ-
ences in chronological age that may confound the anal-
ysis of individual differences in brain measurements and/
or of brain-cognition associations. The volumes of total
iron deposits and white matter hyperintensities were pos-
itively skewed; we thus log-transformed these variables
before including them in the analysis. Analyses were
carried out within R. Missing value analysis revealed
patterns of missing data were random.
Results
Sample characteristics
The descriptive statistics of the imaging and cognitive
variables involved in the analyses are given in Table 1.
Approximately half (48.6%) of the participants from the
sample had hypertension, 10.8 % had diabetes, 41.2 %
had hypercholesterolaemia, 27.2 % had history of car-
diovascular disease and 17.7 % had history of stroke.
Details of the measured values of the continuous car-
diovascular biomarkers on this sample have been report-
ed previously (Wardlaw et al. 2014). Iron deposits in the
corpus striatum, with median volume of 0.03 ml, were
found in 477 participants (70.8 % of the sample). Iron
deposits in the brainstem were found in 87 participants
(12.9 %), in the cortex in 10 (1.5 %), in the white matter
in 42 (6.2 %) and in the thalamus in 8 (1.2 %). Iron
deposits were present in 72.8 % of the sample (490
participants; Table S1 Supplementary Material).
The median total volume of iron deposits was
0.04 ml. The maximum volume of iron deposits found
in the corpus striatum was 2.8 ml, in the brainstem
0.75 ml, in the cortex 0.44 ml, in the white matter
1.4 ml and in the thalamus 0.12 ml. These figures were
affected by previous macrohaemorrhages in the basal
ganglia, cortex and white matter. However, only seven
participants had iron deposits due to previous
macrohaemorrhages in these regions.
Characterisation of iron deposits in the sample
Of the 10 participants who had iron deposits in the
cortex, only 2 presented radiological evidence of a mild
superficial siderosis defined as per Kumar (2009). The
rest were small spherical T2*W hypointensities identi-
fied as microbleeds. Twelve scans presented
microbleeds on the border-zone between white matter
and cortex. The volume and number of ID clusters in the
globus pallidus were more prominent than in other
regions of the corpus striatum (Fig. 1). The corpus
striatum iron deposition load was balanced in both
hemispheres (Figs. 1 and 2). The anatomical distribution
pattern of iron deposits was consistent with those re-
ported by histopathological studies (Ogg and Steen
1998; Morris et al. 1992).
Presence of vascular risk factors, history
of cardiovascular disease, previous stroke and gender
differences in relation to regional iron deposition load
Supplementary Table S2 shows the results of testing the
null hypotheses that the distribution of regional iron de-
posits was the same for men and women and across
subjects with presence or not of vascular risk factors,
history of cardiovascular disease or previous stroke. The
volume of iron deposits in the corpus striatum was
Table 1 Descriptive statistics for the cognitive tests and brain
volumetric variables
Variable type Parameter Number Mean (SD)
Cognitive
test
Digit symbol substitution 656 56.34 (12.20)
Digit span backward 658 7.84 (2.31)
Symbol search 656 24.69 (6.14)
Letter-number sequencing 658 10.97 (3.03)
Block design 656 34.16 (10.08)
Matrix reasoning 656 13.45 (4.90)




Spatial span 655 7.35 (1.37)
Simple reaction time (ms) 657 0.27 (0.05)
Choice reaction time (ms) 657 0.64 (0.09)
Inspection time 645 111.36 (11.77)
Brain
volumetric
Total brain vol. (ml) 676 1123.98 (106.86)
Intracranial vol. (ml) 679 1450.98 (140.57)
Total iron deposit vol. (ml) 651 0.04 (0.20)
Total WMH vol. (ml) 655 7.70 (13.35)
Sample restricted to individuals with usable brain imaging data on
hyperintensities
WMH white matter hyperintensities
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significantly higher for participants with hypercholesterol-
aemia (p=0.002) and history of stroke (p=0.006) vs. those
without. Iron deposits in the brainstem were significantly
higher for men than for women (mean volume 0.020 ml
for men vs. 0.010 ml for women; p=0.002), and for
participants with than without diabetes (p=0.016),
Fig. 1 Number of individual clusters and load of iron deposits
(expressed in ppm of ICV) in the structures of the corpus striatum
for 421/474 datasets. From left to right in the x-axis: left caudate
nucleus (CL), left putamen (PL), left globus pallidus (GL), left
internal capsule (IL), right caudate nucleus (CR), right putamen
(PR), right globus pallidus (GR), right internal capsule (IR), total
volume and count on the left hemisphere (left), on the right (right)
and in both hemispheres (left + right)
Fig. 2 Distributional map of iron deposits on the sample.Maximum intensity projection of the iron deposits on (from left to right) mid-axial,
sagittal and coronal views
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cardiovascular disease (p=0.036) and history of stroke
(p=0.012). Despite few participants having iron deposits
in the white matter, cortex and thalamus, iron deposits in
these regions (i.e., considering each region separately)
were significantly related with history of stroke
(p<0.020). Combining together the iron deposits in white
matter, cortex and thalamus, the difference between par-
ticipants with vs. without hypercholesterolaemia was also
significant (p=0.029). All participants with a history of
stroke had iron deposits, and all participants with iron
deposits in the white matter had at least one stroke.
Neither regional nor total volumes of iron deposition on
participants with hypertension significantly differed from
those on participants reported as normotensive or with low
blood pressure levels. Results for the total volume of iron
deposits, however, were mainly influenced by the preva-
lence of iron deposits in the brainstem and corpus striatum.
The median total ID volume of participants with hyper-
cholesterolaemia was twice as high as of those with nor-
mal cholesterol (0.056 ml, inter-quartile range (IQR)=
0.219 ml vs. 0.028 ml, IQR=0.164 ml, respectively).
Similar proportion in the total ID volume was observed
between participants with diabetes vs. those without it,
with median total ID volumes of 0.067 ml, IQR=
0.285 ml vs. 0.038 ml, IQR=0.184 ml, respectively.
Bivariate relations
A correlation matrix showing the bivariate relations
among the cognitive ability measures, brain variables
and vascular risk factors is shown in Table 2. As expect-
ed, the cognitive measures were highly intercorrelated.
All three later-life cognitive factors were significantly
negatively correlated with total iron deposit volume
(average r=−0.165) and total WMH volume (average
r=−0.126). However, there was no significant correla-
tion between age 11 cognitive ability and either iron
deposits or WMH. Volumes of both iron deposits and
WMH were higher in individuals with hypercholester-
olaemia and stroke, andWMHvolumewas higher in the
presence of hypertension. There were no relations be-
tween the brain measures and either diabetes or cardio-
vascular disease. There was no significant correlation
between the total volume of iron deposits and the total
volume of WMH. Finally, we found that there was no
difference in total iron deposit volume between male
and female cohort members (t(648.35)=1.37, p=0.17);
the same was found for total WMH volume (t(603.08)=
0.15, p=0.88).
Multivariate regression models
We first tested the hypothesis that iron deposits would be
related to cognitive ability even after taking into account
vascular health. The results of the three regression
models predicting total iron deposit volume (one includ-
ing each of the three cognitive ability factors: g-fluid, g-
speed and g-memory) are shown in Table S3 in the
SupplementaryMaterial. In summary, in all threemodels,
cognitive ability was significantly related to iron deposit
volume even after control for all health factors (mean β=
−0.119). After multivariate control, the only health factor
that was consistently related to iron deposit volume was
the participant’s previous history of stroke; that is, the
significant bivariate correlation shown in Table 1
remained significant after inclusion in the model of the
other vascular risk factors.
In the second set of regression models, we used cog-
nitive ability as the dependent variable and included both
iron deposits and WMH as predictors, alongside the
vascular health variables. These results are shown in
Table 3. For all three cognitive factors, both iron deposits
and WMH had significant associations with cognitive
ability: that is, they had separable contributions to
explaining variance in g-fluid, g-speed and g-memory,
although the effect sizes were modest for both iron de-
posits (mean β=−0.140) and WMH (mean β=−0.138).
Finally, we tested whether iron deposits were related
to lifetime cognition, by including in the model the
measure of age 11 cognitive ability (Table 4). We found
that the total volume of iron deposits still predicted all
three cognitive variables after control for age 11 cogni-
tive ability (mean β=−0.101), and WMH still predicted
g-fluid and g-speed (mean β=−0.118), but no longer
significantly predicted g-memory (β=−0.047, p=
0.193). Combined with the lack of correlation between
age 11 intelligence and iron deposits noted above, this
indicated that iron deposits were relevant to later-life
cognitive ability, and were not simply related to pre-
existing cognitive ability from childhood.
Discussion
Associations between brain iron deposits, cognitive
ability, WMH and vascular health
Our results, from analyses of a large sample of older
individuals show a significant and negative association
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between the total volume of iron deposits in the brain
and a variety of cognitive measures. These associations
were above and beyond those of WMH, were still
present after controlling for a number of vascular health
factors, and were unrelated to pre-existing cognitive
ability.
The findings build upon the results of some previous
exploratory studies. For instance, Sullivan et al. (2009)
used quantitative estimates of regional iron concentra-
tion from 10 healthy elderly subjects and found poorer
cognitive ability in those with higher levels of iron
deposition. Penke et al. (2012) examined mineral
Table 2 Correlation matrix for the primary variables used in the analysis
Variable (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
(1) Age 11 MHT –
(2) Fluid intelligence 0.574*** –
(3) Speed 0.402*** 0.760*** –
(4) Memory 0.528*** 0.689*** 0.490*** –
(5) Total iron deposit volume −0.043 −0.177*** −0.172*** −0.145*** –
(6) White matter hyperintensity
volume
−0.075 −0.156*** −0.144*** −0.079* 0.037 –
(7) Hypertension† −0.019 −0.095* −0.087* −0.003 0.059 0.122** –
(8) Diabetes† −0.081 −0.104** −0.126** −0.089* 0.072 0.035 0.141*** –
(9) Hypercholesterolaemia† −0.023 −0.057 −0.089* −0.035 0.101** 0.082* 0.286*** 0.176*** –
(10) Cardiovascular disease† −0.065 −0.018 −0.017 −0.002 0.014 0.019 0.174*** 0.123*** 0.206*** –
(11) Stroke† −0.058 −0.085* −0.075 −0.061 0.150*** 0.171*** 0.139*** 0.088* 0.142*** 0.060
Statistically significant correlations in italics. All brain and cognitive variables controlled for age and sex before calculation of correlations.
Correlations between continuous variables calculated using Pearson correlations; correlations between continuous and categorical variables
calculated using point-biserial correlations; correlations between categorical variables calculated using the phi coefficient
MHT moray house test; all variables aside from age 11 MHT measured at age ∼73
*p<0.05; **p<0.01; ***p<0.001
† =dichotomous variable; all other variables continuous
Table 3 Linear regression models predicting levels of fluid intelligence (model 1), speed (model 2) and memory (model 3) including iron
deposit and white matter hyperintensity volumes. Italic coefficients were statistically significant at p<0.05
Predictor Model 1 Model 2 Model 3
g-fluid g-speed g-memory
(n=644) (n=636) (n=632)
β SE p Adj. R2 β SE p Adj. R2 β SE p Adj. R2
Age −0.120 0.038 0.002 −0.140 0.038 <0.001 −0.083 0.040 0.035
Sex 0.020 0.038 0.595 0.054 0.040 0.151 0.092 0.039 0.020
Total iron deposit volume −0.124 0.038 0.001 −0.190 0.038 0.013 −0.106 0.039 0.007
Total WMH volume −0.138 0.039 <0.001 −0.190 0.039 <0.001 −0.086 0.040 0.034
Hypertension −0.098 0.080 0.222 −0.052 0.080 0.507 0.073 0.083 0.377
Diabetes −0.279 0.126 0.027 −0.323 0.125 0.010 −0.272 0.132 0.039
Hypercholesterolaemia 0.013 0.081 0.869 −0.075 0.081 0.358 −0.011 0.085 0.894
Cardiovascular disease −0.002 0.087 0.977 0.008 0.087 0.930 −0.001 0.091 0.992
Stroke −0.060 0.102 0.556 0.001 0.102 0.994 −0.074 0.106 0.483
0.065 0.089 0.036
WMH white matter hyperintensity
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depositions with iron content from a subsample of 143
participants from the cohort analysed in the present
study. In that subsample, there was a relation between
childhood intelligence and iron deposition. The larger
analysis in the present study shows that this is not, in
fact, the case: there was only a small, non-significant
association between iron deposit volume and early life
cognitive ability in the full LBC1936 sample (r=
−0.043, p=0.282).
At the other end of the life course, however, we found
consistent relations between iron deposit volume and cog-
nitive ability. There were associations, of broadly similar
effect size, between total iron deposit volume and factors
of fluid intelligence, processing speed and memory, all
indexed by a wide range of high-quality cognitive tests.
Including the total volume of WMH as a predictor in the
model as well as iron deposit volume hardly affected the
results: these two types of age-related brain abnormality
had unique, separable associations with cognitive ability.
Controlling for age 11 cognitive ability reduced the effect
sizes somewhat, but the association of iron deposit volume
with cognitive ability remained significant in every case.
This confirmed that the association of iron deposits with
cognitive ability is a later-life phenomenon, and is not
dependent on early life cognitive levels.
In this birth cohort, iron deposits weremore common in
participants with previous evidence (episodic or imaging)
of stroke; indeed, this relation remained significant after
multivariate statistical control for four other related health
concerns (hypertension, diabetes, hypercholesterolaemia
and cardiovascular disease). Hypercholesterolaemia was,
in order of effect size, the secondmost influential factor on
total brain iron accumulation after history of stroke.
Participants with hypercholesterolaemia had significantly
more iron deposits in the corpus striatum than participants
with normal levels of cholesterol, a finding not observed in
relation with iron deposits of any other brain region. All
this suggests that iron deposits of the corpus striatum
might be a better metabolic biomarker than iron deposits
in other brain regions.
In all models, the associations between iron deposits
(and WMH) and cognitive ability remained significant
after controlling for the presence or absence of five health
risk conditions that relate to vascular health (hyperten-
sion, diabetes, hypercholesterolaemia, cardiovascular
disease and occurrence of a previous stroke). It may be
that these diseases (in particular diabetes; see Table 3)
exert separate effects on cognitive ability from any effects
of iron deposition; it may also be that both diabetes and
iron deposits are indicators of a more distal factor that
Table 4 Linear regression models predicting levels of fluid intelligence (model 1), speed (model 2) and memory (model 3), controlling for
childhood cognitive ability (and thus assessing lifetime cognition). Italic coefficients were statistically significant at p<0.05
Predictor Model 1 Model 2 Model 3
g-fluid (*) g-speed (*) g-memory (*)
(n=644) (n=636) (n=632)
β SE p Adj. R2 β SE p Adj. R2 β SE p Adj. R2
Age −0.087 0.032 0.007 −0.130 0.036 <0.001 −0.054 0.034 0.115
Sex −0.048 0.032 0.141 0.008 0.036 0.817 0.023 0.035 0.509
Age 11 MHT 0.550 0.032 <0.001 0.364 0.036 <0.001 0.522 0.034 <0.001
Total iron deposit volume −0.114 0.032 <0.001 −0.097 0.036 0.007 −0.091 0.034 0.008
Total WMH volume −0.088 0.033 0.007 −0.147 0.036 <0.001 −0.046 0.034 0.193
Hypertension −0.120 0.067 0.075 −0.082 0.075 0.277 0.054 0.072 0.449
Diabetes −0.168 0.106 0.112 −0.261 0.119 0.028 −0.163 0.114 0.154
Hypercholesterolaemia 0.027 0.069 0.693 −0.057 0.077 0.461 −0.010 0.074 0.892
Cardiovascular disease 0.029 0.074 0.697 0.007 0.083 0.930 0.044 0.079 0.583
Stroke −0.038 0.086 0.654 0.045 0.097 0.639 0.038 0.091 0.681
0.368 0.220 0.300
MHT moray house test score, WMH white matter hyperintensity volume
*Refers to change from age 11 to age 72.7
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itself lowers cognitive ability. Future research should aim
to test whether there are health and lifestyle factors (such
as smoking) that significantly attenuate the association of
iron deposit volume with cognitive ability in models
similar to ours; that is, they should test for factors that
may cause additional iron to be produced in the brain.
Strengths and limitations
We used visual ratings of microbleeds (Cordonnier et al.
2007), a validated quantitative approach to assess regional
multifocal T2*W hypointensities as a surrogate of the
multifocal brain ID load (Glatz et al. 2013, 2015; Valdés
Hernández et al. 2011, 2014), a validated semi-automatic
WMH segmentation method (Valdés Hernández et al.
2010, 2013b) and measures obtained from comprehensive
batteries of cognitive tests, in an attempt to address our
main research questions. In addition to the robust assess-
ment of the imaging markers, other strengths of this paper
are the analysis of the role thatWMHplay in the effect that
iron deposits have in cognition, explored here for the first
time, and the use of several validated measures of cogni-
tive ability in a large cohort of community-dwelling older
individuals to explore the association between intelligence
and iron deposits in later life.
The sample participants were of similar age and
relatively healthy; thus, the anatomical distribution of
the iron load in this cohort does not allow us to explore
the influence of age in the iron accumulation process.
However, it provides representative evidence of the ID
distribution and its correlates in a healthy septuagenar-
ian European sample, relevant for epidemiological and
ageing studies. In this cohort, iron deposits in the white
matter, thalamus and cortex were found only on few
individuals. This meant that we restricted our analyses
to the total iron deposit volume and did not examine any
potential specific links between iron deposits in partic-
ular regions and cognitive ability. Replication of this
analysis on large studies of patients with conditions like
stroke or dementia is necessary.
The fact that the true volume of iron accumulation in
tissues cannot accurately be determined using MRI
techniques is a caveat of the present study. The volu-
metric measurements of iron are estimates obtained
from measuring the MRI signal produced by the effect
of iron accumulation in tissues. Studies show that, con-
trary to the strong linear correlation between iron con-
centration and the effective transverse relaxation 1/T2*
in the grey matter, in white matter, this correlation is
much weaker (Langkammer et al. 2012; Schweser et al.
2011), affecting the accuracy of computational measure-
ments. This has been attributed to different factors:
different levels of myelin (Langkammer et al. 2012),
the relative volume and oxygenation state of blood (Lee
et al. 2010), chemical exchange between water and
macromolecular protons (Luo et al. 2010; Zhong et al.
2008), the orientation of underlying white matter fibres
with respect to the main magnetic field (Denk et al.
2011) and variations in the macromolecular mass frac-
tion (Mitsumori et al. 2009). To partially overcome this
limitation, we report neuroradiological visual count of
microbleeds: a form of iron deposition predominantly
found on the white matter, which is considered the gold
standard in the study of iron accumulation-related pa-
thologies, along with validated automatic and semi-
automatic assessments, all visually checked and manu-
ally rectified when deemed necessary.
Moreover, old micro-/macro-haemorrhages can ap-
pear as calcifications on conventional MRI (Bradley
1993; Valdés Hernández et al. 2014) and, therefore,
were not included in the volume of brain iron deposi-
tion. Although there is always an overlap in the intensi-
ties that indicate the presence of calcified and non-
calcified iron deposits due to the coalescence of both
minerals in many regions as a consequence of metabolic
processes and the degradation of the non-soluble iron
molecules (Haacke et al. 2005), the sequence combi-
nation of T1W and T2*W (Valdés Hernández et al.
2014) and the filter implemented as part of the
automatic method that assessed the corpus striatum
iron deposits (Glatz et al. 2015), ensured that
heavily calcified regions were not included. This
is a difference with the computational method used
in Penke et al. (2012). Although it is known that
these calcified regions are strongly and directly
associated with the iron deposits assessed (Valdés
Hernández et al. 2014), it has been proposed that
calcification is the latest stage in the iron degrada-
tion and accumulation processes with a neuropro-
tective effect (Casanova and Araque 2003). We
would not predict that the inclusion of these old
micro-/macro-haemorrhages would have changed
the associations found between iron deposition
and cognitive abilities at old age, but it may be
possible that the role of early life general cognitive
ability in the vascular degeneration that occurs at
old age, represented by the presence of brain iron
deposits, may have been underestimated.
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Given the time elapsed between the participants’
assessments (i.e., along 3 years), along which the MR
scanner was serviced twice and upgraded once, the
average intensity value from the T2*W images which
could express relative tissue/regional differences in
iron content, was not measured. Our scanning proto-
col did not produce quantitative R2* (i.e., 1/T2*)
values to determine the regional iron concentration.
Without these additional measures it is difficult to
estimate the degree in which low-level disperse oxi-
dative stress, produced on larger volumes of low iron
concentration, affects cognition as opposed to the
effect that a focal high-concentration source has,
which is reported in this manuscript.
Implications for further research
Although the total iron measures we obtained may
be dominantly influenced by biologically inert forms
as part of ferritin, hemosiderin and other macromol-
ecules, they might be predictive for bioactive iron
compounds and, as such, have relevance for the
study of ageing and neurodegenerative processes
(Pujol et al. 1992; Ward et al. 2014). In our normal
ageing cohort, these iron deposits tended to be found
in the same brain regions in which iron accumulates
in neurodegenerative diseases like Alzheimer’s and
Parkinson’s (Collingwood et al. 2008; Vymazal et al.
1999). This constitutes further evidence that ageing
and some neurodegenerative pathologies share sim-
ilar brain mechanisms involving iron. If brain iron
patterns are characteristic of disease or disease
stages, this might have implications for prediction
and diagnosis.
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